ITGA2B and cancer: In a previous study of patients with different types of cancer, we found a statistical association of increased VTE risk and poor survival rate with lower surface expression of receptors important for platelet activation, namely CD62P and glycoprotein IIb/IIIa, a complex of integrin alpha IIb (ITGA2B) and beta 3 (ITGB3) [5].